How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

BACKGROUND: Empagliflozin has been shown to reduce cardiovascular mortality, but the underlying pathogenetic mechanisms are poorly understood. It was previously demonstrated that empagliflozin improved arterial stiffness. METHODS: Our analysis comprising 58 patients with type 2 diabetes mellitus ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Agnes, Ott, Christian, Jung, Susanne, Striepe, Kristina, Karg, Marina V., Kannenkeril, Dennis, Dienemann, Thomas, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440009/
https://www.ncbi.nlm.nih.gov/pubmed/30922297
http://dx.doi.org/10.1186/s12933-019-0839-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440009/
https://www.ncbi.nlm.nih.gov/pubmed/30922297
http://dx.doi.org/10.1186/s12933-019-0839-8

Ejemplares similares